1
|
Yin TC, Shao MY, Sun M, Zhao L, Lao QY, Yao QL, Bai QM, Yu L, Zhou XY, Wang J. [SRF-rearranged cellular perivascular myoid tumor: a clinicopathological analysis of two cases]. Zhonghua Bing Li Xue Za Zhi 2024; 53:64-70. [PMID: 38178749 DOI: 10.3760/cma.j.cn112151-20230727-00033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 01/06/2024]
Abstract
Objective: To investigate the clinicopathological features, immunophenotype, diagnosis and differential diagnosis of SRF-rearranged cellular perivascular myoid tumor. Methods: Two cases of SRF-rearranged cellular perivascular myoid tumor diagnosed in the Department of Pathology, Fudan University Shanghai Cancer Center from October 2021 to March 2022 were collected. Immunohistochemical staining, fluorescence in-situ hybridization (FISH) and next-generation sequencing (NGS) were performed, and the literature was reviewed. Results: Case 1, a 3-month-old boy presented with a painless tumor of the scalp, measuring about 2 cm in diameter. Case 2, a 3-year-old girl complained with a painless tumor of the knee, measuring approximately 1.5 cm in diameter. Microscopically, the tumor had a clear boundary and showed multinodular growth. The tumor was mainly composed of spindle cells arranged in long intersecting fascicles associated with thin, slit-like or branching ectatic vessels, focally forming hemangiopericytoma-like appearance. The tumor cells were abundant, but there was no obvious atypia. Mitotic figures (3-4/10 HPF) were noted. H-caldesmon and SMA were positive in both cases. Case 1 showed diffuse and strong positivity for Desmin, and focally for CKpan. Ki-67 proliferation index was 20% and 30%, respectively. FISH displayed NCOA2 gene translocation in case 1 and the RELA gene translocation in case 2. NGS detected the SRF-NCOA2 gene fusion in case 1 and the SRF-RELA gene fusion in case 2. Both patients underwent local excisions. During the follow-up of 5-14 months, case 1 had no local recurrence, while case 2 developed local recurrence 1 year post operatively. Conclusions: SRF-rearranged cellular perivascular myoid tumor is a novel variant of perivascular cell tumor, which tends to occur in children and adolescents. The tumor forms a broad morphologic spectrum ranging from a pericytic pattern to a myoid pattern, and include hybrid tumors with a mixture of pericytic and myoid patterns. Due to its diffuse hypercellularity and increased mitotic figures and smooth muscle-like immunophenotype, the tumor is easy to be misdiagnosed as myogenic sarcomas. The tumor usually pursues a benign clinical course and rare cases may locally recur.
Collapse
Affiliation(s)
- T C Yin
- Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Institute of Pathology, Fudan University, Shanghai 200032, China
| | - M Y Shao
- Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Institute of Pathology, Fudan University, Shanghai 200032, China
| | - M Sun
- Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Institute of Pathology, Fudan University, Shanghai 200032, China
| | - L Zhao
- Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Institute of Pathology, Fudan University, Shanghai 200032, China
| | - Q Y Lao
- Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Institute of Pathology, Fudan University, Shanghai 200032, China
| | - Q L Yao
- Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Institute of Pathology, Fudan University, Shanghai 200032, China
| | - Q M Bai
- Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Institute of Pathology, Fudan University, Shanghai 200032, China
| | - L Yu
- Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Institute of Pathology, Fudan University, Shanghai 200032, China
| | - X Y Zhou
- Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Institute of Pathology, Fudan University, Shanghai 200032, China
| | - J Wang
- Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Institute of Pathology, Fudan University, Shanghai 200032, China
| |
Collapse
|
2
|
Kiguchi MM, Fallentine J, Oh JH, Cutler B, Yan Y, Patel HR, Shao MY, Agrawal N, Carmona E, Hager ES, Ali A, Kochubey M, O'Banion LA. Race, sex, and socioeconomic disparities affect the clinical stage of patients presenting for treatment of superficial venous disease. J Vasc Surg Venous Lymphat Disord 2023; 11:897-903. [PMID: 37343787 DOI: 10.1016/j.jvsv.2023.06.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2023] [Revised: 06/01/2023] [Accepted: 06/08/2023] [Indexed: 06/23/2023]
Abstract
OBJECTIVE Superficial venous disease has a U.S. prevalence of nearly 30%, with advanced disease contributing to a significant healthcare burden. Although the risk factors for venous disease are well known, the correlation between race, sex, socioeconomic status, and disease severity on presentation is not well established. The area deprivation index (ADI) is a validated metric with respect to regional geography, social determinants of health, and degree of socioeconomic disadvantage. In the present study, we aimed to identify the disparities and the effect that the ADI, in addition to race and sex, has among patients associated with an advanced venous disease presentation. METHODS A retrospective review between 2012 and 2022 was performed at four tertiary U.S. institutions to identify patients who underwent endovenous closure of their saphenous veins. Patient demographics, state ADI, comorbidities, CEAP (clinical, etiologic, anatomic, pathophysiologic) classification, and periprocedural outcomes were included. Pearson's correlation was performed between the CEAP classification and ADI. Poisson regression analysis was performed to identify factors predicting for an increasing CEAP classification at presentation. Variables with P < .05 were deemed significant. RESULTS A total of 2346 patients underwent endovenous saphenous vein closure during the study period, of whom 7 were excluded because of a lack of follow-up data. The mean age was 60.4 ± 14.9 years, 65.9% were women, and 55.4% were White. Of the 2339 patients, 73.3% presented with an advanced CEAP class (≥3). The mean state ADI for the entire cohort was 4.9 ± 3.1. The percent change in the CEAP classification is an increase of 2% and 1% for every level increase in the state ADI for unadjusted (incidence rate ratio [IRR] = 1.02; P < .001) and adjusted (IRR = 1.01; P < .001) models, respectively. Black race has a 12% increased risk of a higher CEAP class on presentation compared with White race (IRR = 1.12; P = .005). Female sex had a 16% lower risk of a higher CEAP presentation compared with male sex (IRR = 0.84; P < .01). CONCLUSIONS Low socioeconomic status, Black race, and male sex are predictive of an advanced CEAP classification on initial presentation. These findings highlight the opportunity for improved mechanisms for identification of venous disease and at-risk patients before advanced disease progression in known disadvantaged patient populations.
Collapse
Affiliation(s)
- Misaki M Kiguchi
- Department of Vascular Surgery, MedStar Washington Hospital Center, Washington, DC.
| | | | - Jae Hak Oh
- Georgetown University School of Medicine, Washington, DC
| | - Bianca Cutler
- Department of Vascular Surgery, MedStar Washington Hospital Center, Washington, DC
| | - Yueqi Yan
- Biostatistics and Data Support Center, University of California, Merced, Merced, CA
| | - Harik R Patel
- St. George's University of London, London, United Kingdom
| | - Michael Y Shao
- Division of Vascular Surgery, NorthShore University Health System, Chicago, IL
| | - Nishant Agrawal
- Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
| | - Emely Carmona
- Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
| | - Eric S Hager
- Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
| | - Amna Ali
- Division of Vascular Surgery, University of California, San Francisco, Fresno, CA
| | - Mariya Kochubey
- Division of Vascular Surgery, University of California, San Francisco, Fresno, CA
| | - Leigh Ann O'Banion
- Division of Vascular Surgery, University of California, San Francisco, Fresno, CA
| |
Collapse
|
3
|
O'Banion LAA, Shao MY, Ali A, Kochubey M, Yan Y, Fallentine J, Oh JH, Patel HR, Agrawal N, Carmona E, Hager ES, Kiguchi MM. Type IV Hypersensitivity Reaction after Cyanoacrylate Venous Closure. Ann Vasc Surg 2023; 95:218-223. [PMID: 37301253 DOI: 10.1016/j.avsg.2023.06.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2023] [Revised: 05/30/2023] [Accepted: 06/03/2023] [Indexed: 06/12/2023]
Abstract
BACKGROUND Nonthermal endovenous closure techniques are routinely utilized to treat superficial axial venous reflux. Cyanoacrylate closure is a safe and effective modality implemented for truncal closure. However, an adverse reaction of type IV hypersensitivity (T4H), unique to cyanoacrylate, is a known risk. This study aims to evaluate the real-world incidence of T4H and examine risk factors that may predispose its development. METHODS A retrospective review between 2012- and 2022 was performed at four tertiary US institutions to examine patients who underwent cyanoacrylate vein closure of their saphenous veins. Patient demographics, comorbidities, CEAP (Clinical [C], Etiological [E], Anatomical [A], and Pathophysiological [P]) classification, and periprocedural outcomes were included. The primary endpoint was development of T4H post procedure. Logistic regression analysis for risk factors predictive of T4H was performed. Variables with a P-value of <0.05 were deemed significant. RESULTS 595 patients underwent 881 cyanoacrylate venous closures. Mean age was 66.2 ± 14.9, and 66% of patients were female. There were 92 (10.4%) T4H events in 79 (13%) patients. Oral steroids were administered to 23% for persistent and/or severe symptoms. There were no systemic allergic reactions to cyanoacrylate. Multivariate analysis revealed younger age (P = 0.015), active smoking status (P = 0.033), and CEAP 3 (P < 0.001) and 4 (P = 0.005) classifications as independent risk factors associated with development of T4H. CONCLUSIONS This real-world multicenter study shows the overall incidence of T4H to be 10%. CEAP 3 and 4 patients of younger age and smokers predicted a higher risk of T4H to cyanoacrylate.
Collapse
Affiliation(s)
- Leigh Ann A O'Banion
- Division of Vascular Surgery, Department of Surgery, University of California San Francisco-Fresno, Fresno, CA. Leighann.o'
| | - Michael Y Shao
- Division of Vascular Surgery, Northshore University Health System, Chicago, IL
| | - Amna Ali
- Division of Vascular Surgery, Department of Surgery, University of California San Francisco-Fresno, Fresno, CA
| | - Mariya Kochubey
- Division of Vascular Surgery, Department of Surgery, University of California San Francisco-Fresno, Fresno, CA
| | - Yueqi Yan
- University of California Merced, Merced, CA
| | | | - Jae Hak Oh
- Georgetown University School of Medicine, Washington, DC
| | | | - Nishant Agrawal
- Division of Vascular Surgery, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
| | - Emely Carmona
- Division of Vascular Surgery, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
| | - Eric S Hager
- Division of Vascular Surgery, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
| | - Misaki M Kiguchi
- Department of Vascular Surgery, MedStar Washington Hospital Center, Washington, DC
| |
Collapse
|
4
|
Shao MY, Harlin S, Chan B, Santangelo K, Fukaya E, Stoughton J, Kolluri R. VIEW-VLU observational study of the effect of Varithena on wound healing in the treatment of venous leg ulcers. J Vasc Surg Venous Lymphat Disord 2023; 11:692-699.e1. [PMID: 36972751 DOI: 10.1016/j.jvsv.2023.01.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2022] [Revised: 01/26/2023] [Accepted: 01/29/2023] [Indexed: 03/29/2023]
Abstract
OBJECTIVE Chronic venous hypertension, triggered by venous reflux and/or obstruction, leads to skin changes and venous leg ulcers (VLUs). Compression therapy is the standard of care, but many wounds remain unhealed. The objectives of this study were to observe the effects of endovenous chemical ablation with commercially available 1% polidocanol injectable microfoam on VLU healing and recurrence rates. METHODS The VIEW VLU study was a multicenter, open-label, phase IV registry of patients with active VLUs resulting from venous insufficiency of the great saphenous vein and/or anterior accessory saphenous vein systems who underwent ablation with 1% polidocanol microfoam. Primary outcomes included wound healing rate (change in wound perimeter), wound closure at 12 weeks after treatment, and time to wound closure. Secondary outcomes included VLU recurrence, numeric pain score at the ulcer location, EuroQol five-dimension five-level questionnaire quality-of-life index, and the Venous Clinical Severity Score. Patients were followed for 12 months. RESULTS We enrolled 76 patients (80 ulcers) from 14 sites across the United States and Canada (mean age 63.6 ± 13.7 years, 39.5% female, mean body mass index 36.3). Of the enrollees, 96.3% presented with great saphenous vein incompetence. The mean baseline wound perimeter was 117.2 ± 107.4 mm and 26.3% of wounds (21/80) were circumferential. The mean ulcer age was 34.8 ± 51.8 weeks at first presentation and the mean compression therapy duration was 26.4 ± 35.9 weeks. The median wound perimeter decreased by 16.3% from baseline in the first 2 weeks after the procedure and by 27.0% at 12 weeks. By 12 weeks, 53.8% of wounds (43/80) were healed. The median time to ulcer closure by Kaplan-Meier analysis was 89 days (95% confidence interval, 62.0-117.0). In a Kaplan-Meier analysis of initially healed wounds, 88.9% (95% confidence interval, 76.9-94.8) remained closed at 12 weeks after closure. The mean numeric pain scores (ulcer site) improved by 41.0% and 64.1% at 12 weeks and 12 months after the procedure, respectively. The health-related quality-of-life index (scale of 0-1) improved from 0.65 ± 0.27 at baseline to 0.72 ± 0.28 at 12 weeks and 0.73 ± 0.30 at 12 months. By 12 weeks after treatment, the mean target leg Venous Clinical Severity Score had significantly decreased by 5.8 points, and by 12 months it had decreased by 10.0 points. CONCLUSIONS Treatment with 1% polidocanol microfoam was associated with promising wound healing rates and low recurrence rates for VLUs, despite a challenging patient population with recalcitrant ulcers, a large percentage of which were circumferential, in patients with high body mass indexes.
Collapse
Affiliation(s)
- Michael Y Shao
- Swedish Hospital, Northshore University HealthSystem, Chicago, IL.
| | - Stuart Harlin
- University of Texas Health Sciences Center at Houston, Houston, TX
| | - Beverly Chan
- Vascular Health Bronte, Oakville, Ontario, Canada
| | | | - Eri Fukaya
- Stanford University School of Medicine, Palo Alto, CA
| | | | - Raghu Kolluri
- Ohio Health Heart and Vascular Columbus, Columbus, OH
| |
Collapse
|
5
|
O'Banion LA, Ali A, Kochubey M, Yan Y, Fallentine J, Oh JH, Patel HR, Shao MY, Agrawal N, Carmona E, Hager ES, Kiguchi M. Type IV Hypersensitivity Reaction After Cyanoacrylate Venous Closure. Ann Vasc Surg 2023. [DOI: 10.1016/j.avsg.2022.12.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
|
6
|
Cheng L, Xu J, Qian YY, Pan HY, Yang H, Shao MY, Cheng R, Hu T. Interaction between mDia1 and ROCK in Rho-induced migration and adhesion of human dental pulp cells. Int Endod J 2015; 50:15-23. [PMID: 26609804 DOI: 10.1111/iej.12587] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2015] [Accepted: 11/16/2015] [Indexed: 02/05/2023]
Abstract
AIM To investigate the effects of mammalian homologue of Drosophila diaphanous-1(mDia1) and Rho-associated coiled-coil-containing protein kinase (ROCK) on the migration and adhesion of dental pulp cells (DPCs). METHODOLOGY Lysophosphatidic acid (LPA) was used to activate Rho signalling. mDia1 and ROCK were inhibited by short interfering RNA and the specific inhibitor, Y-27632, respectively. The migration of DPCs was assessed using the transwell migration assay and scratch test. Formation of cytoskeleton and focal adhesions(FAs) was observed by confocal laser scanning microscopy. Cell adhesion and spreading assays were performed. Phosphorylation of focal adhesion kinase (FAK) and paxillin was detected by Western blotting, and the bands were analysed using Adobe Photoshop CS5 software. All experiments were performed at least three times, and data were analysed with one-way anova and a post hoc test. RESULTS LPA-triggered activation of Rho and inhibition of ROCK significantly increased the cell migration rate. Cell migration was inhibited by silencing mDia1. mDia1 silencing and ROCK inhibition suppressed the LPA-induced formation of the cytoskeleton, FA and phosphorylation of FAK and paxillin. Inhibition of ROCK or mDia1 facilitated early cell adhesion and spreading; by contrast, the combined inhibition of ROCK and mDia1 neutralized these effects. CONCLUSIONS mDia1 promoted RhoA-induced migration of DPCs, but ROCK had an opposite effect. Both mDia1 and ROCK participated in cytoskeleton formation and adhesion of DPCs. The interactions between mDia1 and ROCK might influence dental pulp repair by determining the migration and adhesion of DPCs.
Collapse
Affiliation(s)
- L Cheng
- State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Chengdu, Sichuan
| | - J Xu
- State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Chengdu, Sichuan
| | - Y Y Qian
- State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Chengdu, Sichuan
| | - H Y Pan
- State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Chengdu, Sichuan
| | - H Yang
- State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Chengdu, Sichuan
| | - M Y Shao
- State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Chengdu, Sichuan.,College of Life Sciences, Sichuan University, Chengdu, Sichuan, China
| | - R Cheng
- State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Chengdu, Sichuan
| | - T Hu
- State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Chengdu, Sichuan
| |
Collapse
|
7
|
Yao N, Zeng Q, Zhong NX, Li DX, Huang LA, Shao MY, Ruan HY. Use of partial least squares path modelling to assess the willingness of Chinese female sex workers to participate in a microbicide trial. Public Health 2015; 129:1187-93. [PMID: 26164187 DOI: 10.1016/j.puhe.2015.06.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2014] [Revised: 01/20/2015] [Accepted: 06/04/2015] [Indexed: 11/26/2022]
Abstract
OBJECTIVES To investigate the willingness of Chinese female sex workers (FSWs) to participate (WTP) in a clinical trial of microbicides; to explore the potential hindrances and facilitating factors; and to provide support for future microbicide clinical trials by tailoring their design to better meet the specific needs of FSWs. STUDY DESIGN Cross-sectional study. METHODS In total, 404 FSWs were investigated using structured questionnaires. Exploratory factor analysis and partial least squares path modelling were used to explore the correlations between several influencing factors and WTP. RESULTS The WTP of FSWs enrolled in this study was high (53.47%, 216/404). Possible benefits from enrolment in the trial were positively associated with WTP, while concern about a hypothetical microbicide, potential physical harm, economic loss from participation, and fear of family or social isolation were negatively associated with WTP. CONCLUSION FSWs are appropriate participants in microbicide clinical trials, and are likely to benefit from effective microbicides. In a microbicide clinical trial, it is imperative to ensure protection of the rights, dignity, safety, confidentiality and welfare of FSW participants.
Collapse
Affiliation(s)
- N Yao
- Department of Medical Statistics, School of Public Health, Chongqing Medical University, Chongqing, PR China; Chongqing Centre for Disease Control and Prevention, Chongqing, PR China
| | - Q Zeng
- Department of Medical Statistics, School of Public Health, Chongqing Medical University, Chongqing, PR China.
| | - N X Zhong
- Department of Medical Statistics, School of Public Health, Chongqing Medical University, Chongqing, PR China
| | - D X Li
- State Key Laboratory for Infectious Disease Prevention and Control, and National Centre for AIDS/STD Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, PR China
| | - L A Huang
- Key Laboratory of Molecular Biology for Infectious Diseases of Ministry of Education, Chongqing Medical University, Chongqing, PR China
| | - M Y Shao
- State Key Laboratory for Infectious Disease Prevention and Control, and National Centre for AIDS/STD Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, PR China
| | - H Y Ruan
- State Key Laboratory for Infectious Disease Prevention and Control, and National Centre for AIDS/STD Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, PR China
| |
Collapse
|
8
|
Pan HY, Yang H, Shao MY, Xu J, Zhang P, Cheng R, Hu T. Sphingosine-1-phosphate mediates AKT/ERK maintenance of dental pulp homoeostasis. Int Endod J 2014; 48:460-8. [PMID: 24931601 DOI: 10.1111/iej.12335] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/25/2013] [Accepted: 06/11/2014] [Indexed: 02/05/2023]
Abstract
AIM To investigate the cell status of dental pulp cells (DPCs) in a sphingosine-1-phosphate (S1P)-induced microinflammation environment and the possible mechanisms of cell homoeostasis maintenance by S1P. METHODOLOGY Sphingosine-1-phosphate receptor (S1PR) expression was examined in DPCs within a local S1P-induced microinflammation model established using 1 μmol L(-1) S1P. U0126 [extracellular signal-regulated kinase (ERK) inhibitor], LY294002 (AKT inhibitor) and Y27632 (ROCK inhibitor) were used to inhibit corresponding signalling pathways of DPCs. CCK8 and cell cycle analysis tested cell proliferation. Immunofluorescence staining JC-1 detected changes of mitochondrial membrane potential (ΔΨm). Tests for apoptosis and the apoptosis-related proteins Bax and Bcl-2 were assessed by flow cytometry and western blot analysis, respectively. Expressions of ERK and AKT were evaluated by western blot analysis. The results were analysed using the Student's t-test and the significance level set at P < 0.05. RESULTS Expressions of S1PR1, S1PR2 and S1PR3 in DPCs differed amongst individuals. DPCs maintained self-homoeostasis in response to S1P-induced microinflammation via S1PRs. During this repair process, ERK, AKT and ROCK had a short-term complementary interaction at 60 min, but then AKT and ERK gradually played decisive roles after 24 h in proliferation enhancement and apoptosis inhibition, respectively (P > 0.05). CONCLUSIONS The AKT-ERK balance may determine whether DPC homoeostasis in S1P-induced microinflammation is maintained by synergistic regulation of cell growth and apoptosis.
Collapse
Affiliation(s)
- H Y Pan
- State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | | | | | | | | | | | | |
Collapse
|
9
|
Advani SJ, Markert JM, Sood RF, Samuel S, Gillespie GY, Shao MY, Roizman B, Weichselbaum RR. Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1. Gene Ther 2011; 18:1098-102. [PMID: 21544094 DOI: 10.1038/gt.2011.61] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Oncolytic viruses have been combined with standard cancer therapies to increase therapeutic efficacy. Given the sequential activation of herpes viral genes (herpes simplex virus-1, HSV-1) and the temporal cellular changes induced by ionizing radiation, we hypothesized an optimal temporal sequence existed in combining oncolytic HSV-1 with ionizing radiation. Murine U-87 glioma xenografts were injected with luciferase encoding HSV-1, and ionizing radiation (IR) was given at times before or after viral injection. HSV-1 replication and tumor-volume response were followed. Radiation given 6-9 h after HSV-1 injection resulted in maximal viral luciferase expression and infectious viral production in tumor xenografts. The greatest xenograft regression was also seen with radiation given 6 h after viral injection. We then tested if HSV-1 replication had a dose response to ionizing radiation. HSV-1 luciferase expression exhibited a dose response as xenografts were irradiated from 0 to 5 Gy. There was no difference in viral luciferase expression as IR dose increased from 5 Gy up to 20 Gy. These results suggest that the interaction of IR with the HSV-1 lytic cycle can be manipulated for therapeutic gain by delivering IR at a specific time within viral replicative cycle.
Collapse
Affiliation(s)
- S J Advani
- Department of Radiation Oncology and Center for Advanced Radiotherapy Technologies, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
| | | | | | | | | | | | | | | |
Collapse
|
10
|
Yang H, Zhu YT, Cheng R, Shao MY, Fu ZS, Cheng L, Wang FM, Hu T. Lipopolysaccharide-induced dental pulp cell apoptosis and the expression of Bax and Bcl-2 in vitro. Braz J Med Biol Res 2010; 43:1027-33. [PMID: 20945038 DOI: 10.1590/s0100-879x2010007500102] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2010] [Accepted: 09/22/2010] [Indexed: 12/23/2022] Open
Abstract
Lipopolysaccharide exerts many effects on many cell lines, including cytokine secretion, and cell apoptosis and necrosis. We investigated the in vitro effects of lipopolysaccharide on apoptosis of cultured human dental pulp cells and the expression of Bcl-2 and Bax. Dental pulp cells showed morphologies typical of apoptosis after exposure to lipopolysaccharide. Flow cytometry showed that the rate of apoptosis of human dental pulp cells increased with increasing lipopolysaccharide concentration. Compared with controls, lipopolysaccharide promoted pulp cell apoptosis (P < 0.05) from 0.1 to 100 μg/mL but not at 0.01 μg/mL. Cell apoptosis was statistically higher after exposure to lipopolysaccharide for 3 days compared with 1 day, but no difference was observed between 3 and 5 days. Immunohistochemistry showed that expression of Bax and Bcl-2 was enhanced by lipopolysaccharide at high concentrations, but no evident expression was observed at low concentrations (0.01 and 0.1 μg/mL) or in the control groups. In conclusion, lipopolysaccharide induced dental pulp cell apoptosis in a dose-dependent manner, but apoptosis did not increase with treatment duration. The expression of the apoptosis regulatory proteins Bax and Bcl-2 was also up-regulated in pulp cells after exposure to a high concentration of lipopolysaccharide.
Collapse
Affiliation(s)
- H Yang
- State Key Laboratory of Oral Diseases, West China College of Stomatology, Sichuan University, Chengdu, China
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Khodarev NN, Roach P, Pitroda SP, Golden DW, Bhayani M, Shao MY, Darga TE, Beveridge MG, Sood RF, Sutton HG, Beckett MA, Mauceri HJ, Posner MC, Weichselbaum RR. STAT1 pathway mediates amplification of metastatic potential and resistance to therapy. PLoS One 2009; 4:e5821. [PMID: 19503789 PMCID: PMC2688034 DOI: 10.1371/journal.pone.0005821] [Citation(s) in RCA: 95] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2009] [Accepted: 05/08/2009] [Indexed: 11/20/2022] Open
Abstract
Background Traditionally IFN/STAT1 signaling is connected with an anti-viral response and pro-apoptotic tumor-suppressor functions. Emerging functions of a constitutively activated IFN/STAT1 pathway suggest an association with an aggressive tumor phenotype. We hypothesized that tumor clones that constitutively overexpress this pathway are preferentially selected by the host microenvironment due to a resistance to STAT1-dependent cytotoxicity and demonstrate increased metastatic ability combined with increased resistance to genotoxic stress. Methodology/Principal Findings Here we report that clones of B16F1 tumors grown in the lungs of syngeneic C57BL/6 mice demonstrate variable transcriptional levels of IFN/STAT1 pathway expression. Tumor cells that constitutively overexpress the IFN/STAT1 pathway (STAT1H genotype) are selected by the lung microenvironment. STAT1H tumor cells also demonstrate resistance to IFN-gamma (IFNγ), ionizing radiation (IR), and doxorubicin relative to parental B16F1 and low expressors of the IFN/STAT1 pathway (STAT1L genotype). Stable knockdown of STAT1 reversed the aggressive phenotype and decreased both lung colonization and resistance to genotoxic stress. Conclusions Our results identify a pathway activated by tumor-stromal interactions thereby selecting for pro-metastatic and therapy-resistant tumor clones. New therapies targeted against the IFN/STAT1 signaling pathway may provide an effective strategy to treat or sensitize aggressive tumor clones to conventional cancer therapies and potentially prevent distant organ colonization.
Collapse
Affiliation(s)
- Nikolai N. Khodarev
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, United States of America
| | - Paul Roach
- Department of Surgery, University of Chicago, Chicago, Illinois, United States of America
| | - Sean P. Pitroda
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, United States of America
| | - Daniel W. Golden
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, United States of America
| | - Mihir Bhayani
- Department of Surgery, University of Chicago, Chicago, Illinois, United States of America
| | - Michael Y. Shao
- Department of Surgery, University of Chicago, Chicago, Illinois, United States of America
| | - Thomas E. Darga
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, United States of America
| | - Mara G. Beveridge
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, United States of America
| | - Ravi F. Sood
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, United States of America
| | - Harold G. Sutton
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, United States of America
| | - Michael A. Beckett
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, United States of America
| | - Helena J. Mauceri
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, United States of America
| | - Mitchell C. Posner
- Department of Surgery, University of Chicago, Chicago, Illinois, United States of America
| | - Ralph R. Weichselbaum
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, United States of America
- * E-mail:
| |
Collapse
|
12
|
Bickenbach KA, Veerapong J, Shao MY, Mauceri HJ, Posner MC, Kron SJ, Weichselbaum RR. Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy. Cancer Gene Ther 2007; 15:133-9. [PMID: 18157146 DOI: 10.1038/sj.cgt.7701103] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
We report the anticarcinogenic, anti-aging polyphenol resveratrol activates the radio- and chemo-inducible cancer gene therapy vector Ad.Egr.TNF, a replication-deficient adenovirus that expresses human tumor necrosis factor alpha (TNF-alpha) under control of the Egr-1 promoter. Like ionizing radiation or chemotherapeutic agents previously shown to activate Ad.Egr.TNF, resveratrol also induces Egr-1 expression from its chromosomal locus with a possible role for Egr-1 promoter CC(A+T)richGG sequences in the expression of TNF-alpha. Resveratrol induction of TNF-alpha in Ad.Egr.TNF-infected tumor xenografts demonstrated antitumor response in human and rat tumor models comparable to that of radio- or chemotherapy-induced TNF-alpha. Although sirtuins are known targets of resveratrol, in vitro inhibition of SIRT1 activity did not abrogate resveratrol induction of Egr-1 expression. This suggests that SIRT1 is not essential to mediate resveratrol induction of Egr-1. Nevertheless, control of transgene expression via resveratrol activation of Egr-1 may extend use of Ad.Egr.TNF to patients intolerant of radiation or cytotoxic therapy and offer a novel tool for development of other inducible gene therapies.
Collapse
Affiliation(s)
- K A Bickenbach
- Department of Surgery, The University of Chicago, Chicago, IL, USA
| | | | | | | | | | | | | |
Collapse
|
13
|
Veerapong J, Bickenbach KA, Shao MY, Smith KD, Posner MC, Roizman B, Weichselbaum RR. Systemic delivery of (gamma1)34.5-deleted herpes simplex virus-1 selectively targets and treats distant human xenograft tumors that express high MEK activity. Cancer Res 2007; 67:8301-6. [PMID: 17804745 DOI: 10.1158/0008-5472.can-07-1499] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Deltagamma(1)34.5 mutant herpes simplex type 1 viruses are under active clinical investigation as oncolytic therapy for cancer. Mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK) activity has been shown to suppress protein kinase R and thereby confer oncolytic susceptibility to some human tumors by R3616, a virus deleted for both copies of gamma(1)34.5. We report that systemic delivery of R3616 can selectively target and destroy human xenograft tumors that overexpress MEK activity compared with tumors that express lower MEK activity. These results suggest systemic delivery of R3616 may be effective in the treatment of some human tumors.
Collapse
Affiliation(s)
- Jula Veerapong
- Department of Surgery, University of Chicago, Chicago, IL 60637, USA
| | | | | | | | | | | | | |
Collapse
|
14
|
Smith KD, Shao MY, Posner MC, Weichselbaum RR. Tumor genotype determines susceptibility to oncolytic herpes simplex virus mutants: strategies for clinical application. Future Oncol 2007; 3:545-56. [DOI: 10.2217/14796694.3.5.545] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Oncolytic Herpes simplex virus -1 (HSV-1) mutants based on deletion of the γ134.5 gene are promising therapies for cancer. Δγ134.5 mutant replication and cytolysis is tumor cell type specific and severely attenuated in normal tissues. The basis for attenuation lies in the activation of the protein kinase R (PKR)-mediated host cellular defense pathway, which inhibits protein synthesis in infected cells. Tumor cells which overexpress MAPK kinase (MEK) activity support robust replication of Δγ134.5 mutants via MEK-mediated inhibition of PKR, resulting in tumor oncolysis. Systemic delivery of γ134.5 mutants may allow selective targeting and destruction of metastases from a broad range of solid human tumors that overexpress MEK. Barriers to systemic HSV-1 oncolytic therapy include innate immunity, adaptive immunity and hepatic adsorption. Immunomodulating agents may overcome innate immunity to HSV-1-based vectors. Preclinical data combined with the pervasiveness of HSV-1 despite widespread immunity suggest that preexisting immunity may not eliminate oncolytic efficacy. In the future, biopsy-determined tumor MEK status may select patients for Δγ134.5 oncolytic therapy.
Collapse
Affiliation(s)
- Kerrington D Smith
- MD Anderson Cancer Center, Department of Surgical Oncology, 1515 Holcombe Blvd. Unit 444, Houston TX 77030, USA
| | - Michael Y Shao
- University of Chicago Medical Center, Department of General Surgery, 5841 S. Maryland Avenue, MC 6040, Chicago, IL 60637, USA
| | - Mitchell C Posner
- University of Chicago Medical Center, 5841 S. Maryland Avenue, MC 5031, Chicago, IL 60637, USA
| | - Ralph R Weichselbaum
- Center for Advanced Medicine 1338, Department of Radiation & Cellular Oncology, 5758 S. Maryland Avenue, MC 9006, Chicago, IL 60637, USA
| |
Collapse
|
15
|
Shao MY, Veerapong J, Bickenbach K, Smith KD, Roizman B, Weichselbaum RR, Posner MC. Systemic delivery by intravenous injection of gamma-1-34.5-deleted HSV-1 for oncolytic viral therapy. J Am Coll Surg 2007. [DOI: 10.1016/j.jamcollsurg.2007.06.219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
16
|
Shao MY, Wang H, Zhu ZM, Yang SL, Li K. Assignment of <i>CRSP9, ETF1</i> and <i>TMEM59</i> genes to porcine chromosomes. Cytogenet Genome Res 2006; 112:342I. [PMID: 16484800 DOI: 10.1159/000089899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2005] [Accepted: 10/13/2005] [Indexed: 11/19/2022] Open
Affiliation(s)
- M Y Shao
- Laboratory of Molecular Biology and Animal Breeding, School of Animal Science and Technology, Huazhong Agricultural University, Wuhan, PR China
| | | | | | | | | |
Collapse
|
17
|
Liu S, Lee S, Wang S, Yeh A, Gau HM, Shao MY. Oxidative dehydrogenation on the alpha-carbon of 4-pyridylacetonitrile complexes of pentaammineruthenium(II). Inorg Chem 2001; 40:6139-43. [PMID: 11703111 DOI: 10.1021/ic000944p] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The oxidation of Ru(NH(3))(5)NCCH(2)py(2+) in 0.10 M HCl turns the solution from yellow to greenish blue with an absorption at lambda = 791 nm. The absorbance reaches its maximum value when the complex undergoes a two-electron oxidation. The IR and (1)H NMR spectra of the product indicate that the metal center remains as Ru(II) and that the ligand is oxidized. The (13)C NMR spectral results suggest that the oxidation product is [(NH(3))(5)RuNCC(pyH)C(pyH)CNRu(NH(3))(5)](ClO(4))(6). Cyclic voltammetry of the product solution also indicates that the oxidation proceeds in two one-electron steps corresponding to [Ru(III),Ru(II)] + e(-) <= => [Ru(II),Ru(II)] and [Ru(III),Ru(III)] + e(-) <= => [Ru(III),Ru(II)]. The structure of the product in deprotonated form [(NH(3))(5)RuNCC(py)C(py)CNRu(NH(3))(5)](ClO(4))(4)(H(2)O)(2) was determined crystallographically. [(NH(3))(5)RuNCC(py)C(py)CNRu(NH(3))(5)](ClO(4))(4)(H(2)O)(2) crystallizes in the orthorhombic Pbca space group with cell constants a = 13.7138 (16) A, b = 15.7553 (18) A, c = 17.831(2) A, and Z = 4. A mechanism for the oxidation has been proposed on the basis of the kinetic studies in the region of 0.01-0.20 M acid concentrations.
Collapse
Affiliation(s)
- S Liu
- Department of Chemistry, Tunghai Christian University, Taichung, Taiwan, ROC
| | | | | | | | | | | |
Collapse
|
18
|
Abstract
The rapid development of numerous therapeutic options for myocardial revascularization requires more advanced, quantitative echocardiographic methods such as measurement of total endocardial and infarct surface area to evaluate myocardial infarction and assess the effects of therapy. Two-dimensional echocardiography is insufficiently quantitative for this purpose because it cannot directly measure three-dimensional relationships with such as volume and surface area. To limitation this limitation we have developed a three-dimensional echocardiograph capable of measuring total and regional or "infarct" surface area. In vitro validation of this method has been carried out comparing computed areas with true areas of a pin model and fixed hearts. Infarcts were demarcated on the fixed hearts by placing pins in the myocardium. The pin heads on the epicardial surface defined infarct regions that could be imaged. True surface areas of the pin model were determined by physical measurement and calculation. True areas of the fixed hearts were determined by planimetry of surface casts made with plastic tape. Accuracies for total and infarct areas were 1.36% and 2.13% for the pin model and 1.61% and 3.48% for the fixed hearts. Interobserver variability for both phantoms was less than 2.5%. The standard error of the estimate predicting total and infarct surface area for the fixed hearts was 1.53 cm2 and 0.71 cm2, respectively (p < 0.001). Three-dimensional echocardiography provides a new, accurate method for directly measuring global and regional surface areas and holds promise for improved evaluation of myocardial infarction and assessment of its treatment.
Collapse
Affiliation(s)
- D L King
- Division of Cardiology, Columbia University College of Physicians and Surgeons, New York, N.Y
| | | | | | | |
Collapse
|
19
|
Gopal AS, King DL, Katz J, Boxt LM, King DL, Shao MY. Three-dimensional echocardiographic volume computation by polyhedral surface reconstruction: in vitro validation and comparison to magnetic resonance imaging. J Am Soc Echocardiogr 1992; 5:115-24. [PMID: 1571165 DOI: 10.1016/s0894-7317(14)80541-5] [Citation(s) in RCA: 106] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Two-dimensional echocardiographic methods of left ventricular volume computation are limited by geometric assumptions and image plane positioning error in the nonvisualized dimension. We evaluated a three-dimensional (3D echocardiographic method that addresses these limitations. Our method uses a volume computation algorithm based on polyhedral surface reconstruction (PSR) and nonparallel, unequally spaced, nonintersecting short-axis planes. Seventeen balloon phantoms were subjected to volume computation by the 3D echocardiography-PSR method and by magnetic resonance imaging (MRI) and compared to true volumes determined by water displacement. The results for 3D echocardiography-PSR were: accuracy = 2.27%, interobserver variability = 4.33%, r = 0.999, SEE = 2.45 ml, and p less than 0.001. Results for MRI were 8.01%, 13.78%, r = 0.995, SEE = 7.01 ml, and p less than 0.001. There was no statistically significant difference between the methods. We conclude that precise image plane positioning and use of the 3D echocardiographic-PSR volume computation method achieves high accuracy and reproducibility in vitro. The excellent in vitro correlation between 3D echocardiography-PSR and MRI indicates that MRI may also serve as an in vivo standard of comparison.
Collapse
Affiliation(s)
- A S Gopal
- Department of Radiology, Columbia University, New York, NY 10032
| | | | | | | | | | | |
Collapse
|